Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Alaunos Therapeutics (TCRT) has a market cap of $2.738 million USD. According to our data, Alaunos Therapeutics is ranked No.9157 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $2.74 M |
-10.47%
|
| Dec 31, 2024 | $3.06 M |
-81.81%
|
| Dec 29, 2023 | $16.81 M |
-89.23%
|
| Dec 30, 2022 | $0.16 B |
-40.37%
|
| Dec 31, 2021 | $0.26 B |
-56.75%
|
| Dec 31, 2020 | $0.61 B |
-46.61%
|
| Dec 31, 2019 | $1.13 B |
152.41%
|
| Dec 31, 2018 | $0.45 B |
-54.83%
|
| Dec 29, 2017 | $0.99 B |
-22.62%
|
| Dec 30, 2016 | $1.29 B |
-35.62%
|
| Dec 31, 2015 | $2.00 B |
63.91%
|
| Dec 31, 2014 | $1.22 B |
16.82%
|
| Dec 31, 2013 | $1.04 B |
4.33%
|
| Dec 31, 2012 | $1.00 B |
-5.67%
|
| Dec 30, 2011 | $1.06 B |
-5.36%
|
| Dec 31, 2010 | $1.12 B |
57.43%
|
| Dec 31, 2009 | $0.71 B |
410.34%
|
| Dec 31, 2008 | $0.14 B |
-83.62%
|
| Dec 31, 2007 | $0.85 B |
-40.70%
|
| Dec 29, 2006 | $1.43 B |
83.69%
|
| Dec 30, 2005 | $0.78 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
 Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
 Autolus Therapeutics
AUTL
|
$0.57 B |
0.000 M
|
UK
|
 Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
 Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
 Precigen
PGEN
|
$0.33 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
| Market Cap | = | TCRT Stock Price | * | TCRT Shares Outstanding |
| = | $1.71 | * | 1.60 M | |
| = | $2.74 M |